On 10th to 13th May, 2014, the 7th international conference on ubiquitination and ubiquitin protein was held in Shanghai Jiaotong University. This conference was jointly organized by the university of Texas MD Anderson Cancer Center and Shanghai Jiaotong University. Many famous scientists came together to discuss this significant emerging field on the clinical application.
Original Title
The 7th International Conference on Ubiquitination and Ubiquitin
On 10th to 13th May, 2014, the 7th international conference on ubiquitination and ubiquitin protein was held in Shanghai Jiaotong University. This conference was jointly organized by the university of Texas MD Anderson Cancer Center and Shanghai Jiaotong University. Many famous scientists came together to discuss this significant emerging field on the clinical application.
On 10th to 13th May, 2014, the 7th international conference on ubiquitination and ubiquitin protein was held in Shanghai Jiaotong University. This conference was jointly organized by the university of Texas MD Anderson Cancer Center and Shanghai Jiaotong University. Many famous scientists came together to discuss this significant emerging field on the clinical application.
The 7th International Conference on Ubiquitination and Ubiq
uitin Protein
On 10th to 13th May, 2014, the 7th internati
onal conference on ubiquitination and ubi quitin protein was held in Shanghai Jiaoto ng University. This conference was jointly organized by the university of Texas MD A nderson Cancer Center and Shanghai Jiao tong University. Many famous scientists c ame together to discuss this significant e merging field on the clinical application.
This conference was mainly focusing on esti
mating the most effective target and the ne w drugs of targeting molecules. Attendees would have a deep learn about the research progress of this technology. These progress will be connected with the treatment of tum ors and the most advanced treatment. Wha ts more, it will contribute a lot to researche s of cancer treatment and other diseases.
Ubiquitination and uibiquitin protein are playing an important rol
e in protein post-translational modification. They are very signific ant substances in the cell regulation, cell differentiation, cell sign aling pathway. According to the research of anemia, ubiquitinatio n and uibiquitination protein have a close relationship with this d isease. There was a paper published on CELL magazine, which wa s mainly focusing on the anemia. This article showed that hypoxi a-inducible factor (1) will occur SUMO modification under the h ypoxia condition. This will promote the combination of HIF 1 an d Hippel-Lindau. And then the ubiquitination degradation will occ ur. So we can conclude that the formation of red blood cells is re gulated by the ubiquitination and SUMO, which will pave a new w ay for the research of clinical treatment.
Ubiquitination is a low component protein. It mean
s that ubiquitination moleculars modify the target p roteins with the help of enzymes. Some special enzy mes will classify the proteins in the body to pick up the target proteins. It is very important in the localiz ation, metabolism, function, regulation and degrada tion of proteins. The process of ubiquitination is a li ttle complicated. The main three enzymes are ubiqu itin activating enzyme, ubiquitin conjugating enzym e and ubiquitin ligase. The reaction of the three enz ymes are the main process of ubiquitination.
We introduce applications of ubiquitinatio
n and ubiquitination proteins in all kinds of diseases and researches. We can concl ude that the function of ubiquitination is attracting more and more attention of sci entists and doctors. The future of this fiel d is bright and we all believe that the ubiq uitination technology will play a very imp ortant role in our future biotechnology.